• SB203580 Workflow for p38 MAPK Inflammation Studies

  2026-09-05

  Build cleaner p38 MAPK experiments with SB203580, from soluble stock preparation to epithelial–neutrophil chemotaxis assays. The workflow connects pathway inhibition with inflammation, neuroprotection studies, and multidrug resistance reversal while highlighting concentration-dependent kinase selectivity and practical troubleshooting.

• Pam3CSK4: A Calibrated TLR1/2 Inflammation Probe

  2026-09-04

  Pam3CSK4 is a defined TLR1/2 agonist for dissecting immune activation, allergic inflammation, and neuroimmune regulation. This article presents a causal assay framework that separates direct innate immune signaling from TRPV1-driven systemic anti-inflammatory reflexes.

• Nerve-Driven HDAC1 Control in Axolotl Regeneration

  2026-09-04

  Wang and colleagues show that nerve-dependent HDAC1 expression is required for blastema formation and successful limb regeneration in axolotls. Their combination of pharmacological inhibition, denervation, and nerve-factor supplementation links neural signaling to epigenetic regulation at the wound epidermis, providing a mechanistic framework for studying regeneration.

• Vancomycin hydrochloride: Assay Reliability Guide

  2026-09-03

  This scenario-driven guide explains how Vancomycin hydrochloride, SKU B1223, can support Gram-positive bacteria inhibition, bacterial susceptibility testing, and antibiotic resistance assay design without being misapplied as a direct mammalian-cell viability reagent. It connects documented solubility, storage, and infection-model information with practical controls for reproducible laboratory workflows.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody for HMGB1

  2026-09-03

  Use this Cy3-labeled secondary antibody to convert mouse anti-HMGB1 binding into a sensitive, imageable signal across immunofluorescence, flow cytometry, and western blot workflows. The approach complements quantitative proteomics by adding spatial and cell-level validation for early diabetic nephropathy research.

• BIBR 1532: A Translational Playbook for Telomerase

  2026-09-02

  BIBR 1532 provides a mechanistically defined way to interrogate hTERT inhibition, telomere attrition, cancer cell proliferation inhibition, and apoptosis. This thought-leadership guide connects leukemia evidence with emerging telomere-focused combination biology while outlining a disciplined translational workflow.

• Moxifloxacin: Mechanism-to-Readout Assays

  2026-09-02

  Moxifloxacin is a fluoroquinolone antibiotic whose value extends beyond antibacterial screening. This guide presents a decision-based framework for connecting gyrase assays with retinal-cell, metabolic, and toxicity readouts while preserving mechanistic rigor.

• Exo1 for Golgi–ER Traffic and Exocytosis

  2026-09-01

  Exo1, or methyl 2-(4-fluorobenzamido)benzoate, provides an acute way to interrogate Golgi–ER membrane traffic and exocytic phenotypes. This article connects its ARF1-centered mechanism with tumor extracellular vesicle assays while clearly separating established evidence from hypothesis-generating applications.

• IR-820 for Near-Infrared Imaging Workflows

  2026-09-01

  IR-820 (New Indocyanine Green) supports practical vascular mapping, tumor visualization, and diseased tissue quantification with near-infrared fluorescence imaging. This guide translates its optical properties into a controlled workflow and shows how the reference study can inform, but not replace, direct validation of IR-820 in photothermal nanomedicine assays.

• ALT Cancer Cells and ATR Inhibition: No General Sensitivity

  2026-08-31

  Deeg and colleagues tested whether alternative lengthening of telomeres (ALT) creates a broadly exploitable vulnerability to the ATR inhibitor VE-821. Across multiple cell models and an isogenic ALT-suppression system, the study found no general ALT-associated hypersensitivity, emphasizing the importance of cell-line context and experimental controls.

• T3, Spatial Biology, and Translational Metabolism

  2026-08-31

  Triiodothyronine can serve as a controlled endocrine input for metabolic and oligodendrocyte research, while spatially concentrated adenine base editors offer a complementary strategy for correcting PLP1 mutations. This article connects both concepts without overstating evidence, outlining rigorous validation, workflow controls, and translational opportunities.

• Alternariol, LX-2 Cells, and Liver Fibrosis

  2026-08-30

  The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can drive LX-2 hepatic stellate cells toward a contractile, fibrotic myofibroblast phenotype, whereas tenuazonic acid produced no significant effect in the tested model. By combining lncRNA–mRNA omics with pathway and detoxification experiments, the work connects emerging Alternaria toxin exposure with NF-κB signaling, ferroptosis, autophagy, and a CotA laccase-based mitigation strategy.

• Praeruptorin A: Applied Research Workflows

  2026-08-29

  Praeruptorin A is a multi-target angular pyranocoumarin compound for connecting ferroptosis, inflammation, barrier injury, cardiomyopathy, and tumor invasion assays in one research program. This workflow-focused guide covers solvent handling, concentration design, orthogonal readouts, causal validation, and troubleshooting for more reproducible bench studies.

• Vancomycin Hydrochloride for Resistance Assays

  2026-08-28

  Vancomycin hydrochloride is a mechanistically precise glycopeptide antibacterial agent for Gram-positive bacteria inhibition and bacterial susceptibility testing. This guide shows how to use it as an interpretable control across resistance assays while distinguishing susceptibility endpoints from PK/PD conclusions.

• Golgi-Tracker Green for Live-Cell Golgi Imaging

  2026-08-28

  Golgi-Tracker Green enables selective, photostable visualization of Golgi membranes in living cells using BODIPY FL-labeled C5-ceramide. This article translates the probe into practical workflows for Golgi morphology, lipid transport, sphingolipid metabolism, and mechanistic cancer assays while emphasizing live-cell limitations and troubleshooting.

8484 records 1/566 page Next 12345 下5页 Last page